A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
Rachid Rafia, Marrissa Martyn‐St James, S Harnan, Andrew Metry, Jean Hamilton, Allan Wailoo
Topics & Concepts
MedicineQuality-adjusted life yearHazard ratioCost–benefit analysisWillingness to payCost-effectiveness analysisQuality of life (healthcare)Coronavirus disease 2019 (COVID-19)Cost effectivenessConfidence intervalRisk analysis (engineering)Internal medicineEconomicsDiseaseInfectious disease (medical specialty)NursingMicroeconomicsEcologyBiologyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19